Clever Leaves Holdings Inc. (CLVR) vs Citius Oncology, Inc. (CTOR)
- Clever Leaves Holdings Inc. CLVR 0.01 0.00%
- Citius Oncology, Inc. CTOR 0.75 0.00%
Clever Leaves Holdings Inc. and Citius Oncology, Inc. are both Drug Manufacturers Specialty & Generic companies. Clever Leaves Holdings Inc. is the larger, with a market value of $96.5M against $69.4M — 1.4× the size. Citius Oncology, Inc. has the higher net margin (0.00% vs −102.8%) and the lower return on invested capital (−67.2% vs −52.6%). Across the 13 metrics below, Clever Leaves Holdings Inc. leads on 7 and Citius Oncology, Inc. on 6.
Valuation
| Metric | CLVR | CTOR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 19.25 |
| P/S | 0.00 | n/m | 2.11 |
| P/B | 0.00 | 2.00 | 1.78 |
| Price to free cash flow | n/m | n/m | 16.14 |
| EV/EBITDA | 0.44 | n/m | 12.58 |
| EV/Sales | (0.33) | n/m | 2.73 |
| Earnings yield | (113,051.00%) | (62.67%) | (4.38%) |
| Free cash flow yield | (55,338.01%) | (39.72%) | 0.00% |
Profitability
| Metric | CLVR | CTOR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 37.64% | — | 53.94% |
| Operating margin | (89.53%) | 0.00% | 0.00% |
| Net margin | (102.77%) | 0.00% | 0.00% |
| Free cash flow margin | (49.82%) | 0.00% | 0.00% |
| Return on equity | (55.39%) | (126.58%) | (0.40%) |
| Return on assets | (42.95%) | (45.20%) | (3.32%) |
| Return on invested capital | (52.59%) | (67.15%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack